Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Applied Microbiology and Biotechnology|December 29, 2000
Recombinant expression analysis of natural and synthetic bovine alpha-casein in Escherichia coliS K Goda, A F Sharman, M Yates, et al.
Gene Therapy|February 1, 1996
Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridiaM E Fox, M J Lemmon, M L Mauchline, et al.
Gene Therapy|August 1, 1997
Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironmentM J Lemmon, P van Zijl, M E Fox, et al.
European Journal of Biochemistry|April 20, 1990
The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding geneD E Thompson, J K Brehm, J D Oultram, et al.
Microbiology Spectrum|February 2, 2022
A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage ReceptorM J Whittle, T W Bilverstone, R J van Esveld, et al.
Gene|January 1, 1986
Cloning, expression and complete nucleotide sequence of the Bacillus stearothermophilus L-lactate dehydrogenase geneD A Barstow, A R Clarke, W N Chia, et al.
FEMS Microbiology Reviews|October 1, 1995
Chemotherapeutic tumour targeting using clostridial sporesN P Minton, M L Mauchline, M J Lemmon, et al.
British Journal of Cancer|May 27, 2004
Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)A Mayer, S K Sharma, B Tolner, et al.
Immunotechnology : an International Journal of Immunological Engineering|February 1, 1996
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion proteinN P Michael, K A Chester, R G Melton, et al.
British Journal of Cancer|October 7, 2006
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivoJ Theys, O Pennington, L Dubois, et al.
Pageof 5